Skip to main content
OpenTrials
Completed

NCT Number: NCT02656823

Implant-fixed Restorations With ANKYLOS 6.6 mm Implants in the Edentulous Maxilla - A 5-year Follow-up Study

Study to assess the performance of six short implants (ANKYLOS C/X 6.6 mm) in the edentulous maxilla supporting fixed full-arch bridges after 5 years in function.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Nova Southeastern University

Fort Lauderdale, Florida, 33328, United States

About this study

Study to assess the performance of six short implants (ANKYLOS C/X 6.6 mm) in the edentulous maxilla supporting fixed full-arch bridges after 5 years in function. The primary objective was to evaluate implant survival.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

For inclusion in the study subjects had to meet all of the following criteria:

  • Aged 18-80 years at inclusion.
  • Signed informed consent.
  • In need of full-arch restoration of the maxilla.

The following should be considered at inclusion but should be fulfilled at Implant Placement (Visit 3):

  • Maxilla: totally edentulous, fulfilling all of the following criteria:
  • History of edentulism: ≥ 6 months and,
  • Minimum bone height: ≥ 7 mm and,
  • Minimum bone width: ≥ 5.5 mm.
  • Mandible: antagonistic natural dentition or tooth/implant borne rehabilitation which can be used to create a stable occlusal fit with the new full-arch restoration of the upper jaw.

Exclusion criteria

Any of the following was regarded as a criterion for exclusion from the study:

  • Unlikely to be able to comply with study procedures according to Investigator's judgement.
  • History of bone augmentation in the maxilla within 6 months prior to surgery.
  • Uncontrolled pathologic processes in the oral cavity.
  • Bruxism.
  • Smoking >10 cigarettes per day.
  • Present alcohol or drug abuse.
  • History of radiation therapy in head and neck region.
  • History of chemotherapy within 5 years prior to surgery.
  • Condition that would compromise post-operative tissue healing or osseointegration.
  • Bisphosphonates or any other medication that would compromise post-operative healing or osseointegration.
  • Known pregnancy at time of inclusion.
  • Current or former participation in a clinical study that may interfere with the present study.
  • Involvement in the planning and conduct of the study.

Treatment and study plan

ANKYLOS C/X implant A 6.6

Device

Treatment with six (6) 6.6 mm implants and a bridge to restore chewing function of an edentulous maxilla.

Primary outcomes

  1. Implant Survival Rate

    Time frame: At Visit 14, 5 years after permanent restoration (PR).

    Any implant that is removed after implant placement will be considered failure, whatever reason for removal. Implant survival will be evaluated clinically and radiographically by counting the number of remaining implants.

Secondary outcomes

  1. Implant Stability

    Time frame: At implant placement (IP) (Visit 3), and at Abutment surgery and Impression (Visit 5, at 13 weeks after IP).

    Implant stability was evaluated clinically/manually by the investigator at implant placement visit (this initial manual check is called primary stability), and again at the abutment surgery visit. The stability evaluation was recorded as yes/no, yes = judged by the investigator to be stable, or no = judged by the investigator to be unstable. Stability was assessed at implant placement (IP) (Visit 3), and at Abutment Surgery and Impression (Visit 5, at 13 weeks after IP).

  2. Mean Marginal Bone Level (MBL) at Subject's Tissue Level

    Time frame: At permanent restoration (PR) (Visit 8, at 17 weeks after IP), and at 1-year after PR (Visit 10), at 3-years after PR (Visit 12), and at 5-years after PR (Visit 14).

    The mean Marginal Bone Level (MBL) on subject level. Bone level response will be evaluated from intra-oral radiographs. The radiographs will be sent for central evaluation to a radiologist who is independent from the investigational group and the Sponsor. The radiologist will measure and record the distance from a reference point on the implant to the most coronal bone-to-implant contact on the mesial and distal aspect of the implant. The reference point is defined as the implant shoulder.

  3. Mean Marginal Bone Level (MBL) on Implant Level.

    Time frame: At permanent restoration (PR) (Visit 8, at 17 weeks after IP), and at 1-year after PR (Visit 10), at 3-years after PR (Visit 12), and at 5-years after PR (Visit 14).

    The mean Marginal Bone Level (MBL) on implant level. Bone level response will be evaluated from intra-oral radiographs. The radiographs will be sent for central evaluation to a radiologist who is independent from the investigational group and the Sponsor. The radiologist will measure and record the distance from a reference point on the implant to the most coronal bone-to-implant contact on the mesial and distal aspect of the implant. The reference point is defined as the implant shoulder.

  4. Mean Probing Pocket Depth (PPD) at Subject Level.

    Time frame: At permanent restoration (PR) (Visit 8, at 17 weeks after IP), and at 6-months after PR (Visit 9), at 1-year after PR (Visit 10), at 2-years after PR (Visit 11), at 3-years after PR (Visit 12), and at 5-years after PR (Visit 14).

    PPD was measured as the distance from the mucosal margin to the bottom of the probeable pocket in mm.

  5. At Least One Surface With Plaque.

    Time frame: At permanent restoration (PR) (Visit 8, at 17 weeks after IP), and at 6-months after PR (Visit 9), at 1-year after PR (Visit 10), at 2-years after PR (Visit 11), at 3-years after PR (Visit 12), and at 5-years after PR (Visit 14).

    Plaque was recorded as presence or absence of plaque by visual inspection on four surfaces at each implant site (mesially, distally, buccally and lingually).

  6. Any Bleeding on Implant (BoP)

    Time frame: At permanent restoration (PR) (Visit 8, at 17 weeks after IP), and at 6-months after PR (Visit 9), at 1-year after PR (Visit 10), at 2-years after PR (Visit 11), at 3-years after PR (Visit 12), and at 5-years after PR (Visit 14).

    BoP was evaluated at each of the four surfaces around the implant site (mesially, distally, buccally and lingually), by using a periodontal probe. BoP was recorded as presence or absence of bleeding when probing to the bottom of the pocket.

  7. Oral Health Impact Profile 14 (OHIP-14)

    Time frame: At pre-surgical planning (Visit 2) on average 6 months before PR, and at 6-months after PR (Visit 9), at 1-year after PR (Visit 10), at 2-years after PR (Visit 11), at 3-years after PR (Visit 12), and at 5-years after PR (Visit 14).

    Patient satisfaction was evaluated using the Oral Health Impact Profile 14 (OHIP-14). The questionnaire was filled in by the subjects before and after treatment with implants. OHIP-14 includes seven domains: functional limitation, pain, psychological discomfort, physical disability, psychological disability, social disability, and handicap. An example of an OHIP statement is "Have you had to interrupt meals because of problems with your teeth, mouth or dentures". Responses are based on a Likert scale (i.e., 0 = never, 1 = hardly ever, 2 = occasionally, 3 = fairly often, 4 = very often). The lowest possible total score (all question responses summed) of the OHIP-4 questionnaire is 0, and the highest possible score is 56. A high score is linked to a poor outcome.

  8. Prosthetic Survival Rate on Subject Level

    Time frame: At 1-year after PR (Visit 10), at 2-years after PR (Visit 11), at 3-years after PR (Visit 12), and at 5-years after PR (Visit 14).

    A prosthetic restoration was considered a survived if the original restoration was still in place, regardless of its condition, at the follow-up visit.

Sponsors and collaborators

Lead sponsor

Dentsply Sirona Implants and Consumables

Industry

Registry information

Official study title

Implant-fixed Restorations With Short Implants in the Edentulous Maxilla - A Clinical Investigation Over a 5-year Follow-up Period

Important dates

Study start
2015
Primary completion
2022
Study completion
2022
First posted
Jan 15, 2016
Registry last updated
Feb 28, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.